Cardiac Nuclear Imaging

Overview

Cardiac nuclear imaging evaluates myocardial perfusion metabolism and viability. SPECT and PET are common modalities for ischemia and viability assessment. These studies inform revascularization and medical therapy decisions.

Perfusion Imaging

Myocardial perfusion imaging detects ischemia and infarction. Stress and rest protocols assess reversible perfusion defects. Quantitative measures support risk stratification.

Metabolic and Viability

FDG PET assesses myocardial metabolism and viability in hibernating myocardium. Viability imaging guides revascularization decisions in selected patients. Integration with anatomical imaging improves localization.

Practical Considerations

Patient preparation and tracer selection affect study quality. Attenuation correction and gating improve diagnostic accuracy. Collaboration with cardiology optimizes clinical impact.

PET Imaging

Overview

Positron emission tomography uses radiotracers to image metabolic activity. It provides functional information about tissues. It is often combined with CT or MRI for localization.

Clinical Applications

PET is used in oncology neurology and cardiology. It detects metabolic activity of tumors and brain disorders. It guides therapy selection and response assessment.

Radiotracers

Common tracers include FDG and others for specific targets. Tracer selection depends on clinical question. Radiochemistry advances expand tracer availability.

Hybrid Imaging

PET CT and PET MRI combine functional and anatomic data. These hybrids improve diagnostic accuracy and staging. They are valuable in complex cases.

PET CT Scanner

Overview

PET CT combines positron emission tomography with CT for precise localization of metabolic activity. It is widely used in oncology cardiology and neurology. Hybrid imaging improves staging and therapy monitoring.

Tracer Handling

Radiotracer production logistics and timing are critical for PET studies. FDG is the most common tracer but many specialized tracers exist. Proper handling and quality control ensure reliable imaging.

Attenuation Correction

CT based attenuation correction improves PET quantification and image quality. Accurate registration between PET and CT is essential for interpretation. Motion management reduces misregistration artifacts.

Operational Considerations

Scanner calibration and daily QC maintain quantitative accuracy. Radiation safety protocols govern tracer handling and patient care. Scheduling accounts for tracer uptake times and scanner throughput.

Positron Emission Tomography PET

Overview

PET images physiologic and metabolic processes using radiotracers such as FDG and detects areas of altered metabolism with high sensitivity.

Technique

Radiotracer selection uptake time and attenuation correction are critical. PET is often combined with CT or MRI for anatomic localization.

Clinical Uses

Oncology staging and response assessment infection and inflammation imaging and neurologic metabolic studies.

Limitations and Safety

Radiation exposure from radiotracers and CT component. False positives from inflammatory uptake require clinical correlation.